August 4, 2026 · earnings
SYRE earnings: a positive outcome, +10.5%
On August 4, 2026, Spyre Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.5% in the window around the event. It had already run +13.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$94.93
1d before
$104.94
Event day
$104.35
1d after
$104.91
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.3% expected); the stock actually moved +10.5%. Model confidence at the time: 100%.
See the full scored track recordPre-catalyst setup
+13.5%
30-day run-up
6252%
30-day volatility
0.8×
volume spike